NephroGenex (NRX) To Present At BioEquity Europe 2014 Conference
5/20/2014 7:11:06 AM
NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Pierre Legault, Chief Executive Officer, will present a corporate overview at the 15th annual BioEquity Europe conference at the Hilton Amsterdam Hotel in Amsterdam.
Help employers find you! Check out all the jobs and post your resume.
comments powered by